Sugi Predict

Sugi Predict / Compounds / SCHEMBL742923

SCHEMBL742923

SCHEMBL742923

CCCCCCCC/C=C\CCCCCCCC(=O)O[C@@H]1CC[C@@]2(C)[C@@H](C1)C[C@@H](O)[C@@H]1[C@@H]2C[C@H](O)[C@]2(C)[C@@H]([C@H](C)CCC(=O)O)CC[C@@H]12

nearest known ligand 0.65

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ GPBAR1 Q8TDU6 7/20 0.65
▸ NR1H4 Q96RI1 4/20 0.65
▸ CYP3A4 P08684 3/20 0.65
▸ PDE3A Q14432 1/20 0.65
▸ LMNA P02545 2/20 0.61
▸ KMT2A Q03164 4/20 0.58
▸ MEN1 O00255 3/20 0.58
▸ SLCO1B3 Q9NPD5 1/20 0.58
▸ SLCO1B1 Q9Y6L6 1/20 0.58
▸ USP2 O75604 1/20 0.58
▸ ABCB11 O95342 2/20 0.57
▸ TDP1 Q9NUW8 2/20 0.55
▸ ALDH1A1 P00352 1/20 0.55
▸ CYP8B1 Q9UNU6 1/20 0.52
▸ CYP2C19 P33261 1/20 0.51
▸ CHRM2 P08172 1/20 0.51
▸ ADRA2A P08913 1/20 0.51
▸ ADRA1A P35348 1/20 0.51
▸ SLC10A2 Q12908 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4760084 0.88 CYP3A4 (0.58) GPBAR1NR1H4CYP3A4PDE3ALMNA
SCHEMBL5680725 0.87 ALDH1A1 (0.71) GPBAR1NR1H4CYP3A4PDE3ALMNA
SCHEMBL23231225 0.87 GPBAR1 (0.83) GPBAR1NR1H4CYP3A4PDE3ALMNA
SCHEMBL25791223 0.87 GPBAR1 (0.83) GPBAR1NR1H4CYP3A4PDE3ALMNA
SCHEMBL25791298 0.87 GPBAR1 (0.83) GPBAR1NR1H4CYP3A4PDE3ALMNA
SCHEMBL23222957 0.87 GPBAR1 (0.83) GPBAR1NR1H4CYP3A4PDE3ALMNA
SCHEMBL2553341 0.87 GPBAR1 (0.83) GPBAR1NR1H4CYP3A4PDE3ALMNA
SCHEMBL437404 0.87 GPBAR1 (0.83) GPBAR1NR1H4CYP3A4PDE3ALMNA
SCHEMBL21114412 0.87 GPBAR1 (0.83) GPBAR1NR1H4CYP3A4PDE3ALMNA
SCHEMBL10826386 0.86 GPBAR1 (0.82) GPBAR1NR1H4CYP3A4PDE3ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 60 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4389893-A1 HUMAN TRANSFERRIN RECEPTOR BINDING PEPTIDE-DRUG CONJUGATE Takeda Pharmaceutical Company Limited (JP) 2024-06-26 — — EP disclosed
WO-2024106539-A1 LIGAND CONJUGATE SUBSTANCE, NUCLEIC ACID CONTAINING SAME, AND USE THEREOF 株式会社ボナック 2024-05-23 — — WO disclosed
EP-3659609-B1 THERAPEUTIC AGENT FOR FIBROSIS KYORIN SEIYAKU KK (JP) 2024-05-08 — — EP disclosed
WO-2024061185-A1 SPECIFICALLY MODIFIED RNAI REAGENT AND COMPOSITION 上海舶望制药有限公司 2024-03-28 — — WO disclosed
WO-2023202686-A1 COMPOSITION AND METHOD FOR INHIBITING XANTHINE DEHYDROGENASE (XDH) 上海舶望制药有限公司 2023-10-26 — — WO disclosed
WO-2023186056-A1 COMPOSITION AND METHOD FOR INHIBITING EXPRESSION OF COMPLEMENT COMPONENT C3 PROTEIN 上海舶望制药有限公司 2023-10-05 — — WO disclosed
WO-2023138689-A1 COMPOSITION AND METHOD FOR INHIBITING EXPRESSION OF PROTEIN LPA(APO(A)) 上海舶望制药有限公司 2023-07-27 — — WO disclosed
WO-2023134609-A1 RNAI AGENT INHIBITING PCSK9 GENE EXPRESSION AND APPLICATION THEREOF 石药集团中奇制药技术（石家庄）有限公司 2023-07-20 — — WO disclosed
EP-4206325-A1 NOVEL NUCLEIC ACID MOLECULE INHIBITING EXPRESSION OF TARGET GENE BONAC CORPORATION (JP) 2023-07-05 — — EP disclosed
WO-2023088227-A1 COMPOSITION AND METHOD FOR INHIBITING ANGIOTENSINOGEN (AGT) PROTEIN EXPRESSION 上海舶望制药有限公司 2023-05-25 — — WO disclosed
US-20140329886-A1 SINGLE-STRANDED NUCLEIC ACID MOLECULE HAVING AMINO ACID BACKBONE BONAC CORPORATION (JP) 2014-11-06 — — US disclosed
US-8785121-B2 Single-stranded nucleic acid molecule for controlling gene expression BONAC CORPORATION (JP) 2014-07-22 — — US disclosed
US-20140171633-A1 Single-Stranded Nucleic Acid Molecule Having Nitrogen-Containing Alicyclic Skeleton BONAC CORPORATION (JP) 2014-06-19 — — US disclosed
US-20140171486-A1 Single-Stranded Nucleic Acid Molecule Having Nitrogen-Containing Alicyclic Skeleton BONAC CORPORATION (JP) 2014-06-19 — — US disclosed
EP-2674494-A1 Single-stranded RNA molecule having nitrogen-containing alicyclic skeleton Bonac Corporation (JP) 2013-12-18 — — EP disclosed
EP-2436767-B1 Single-stranded RNA molecule having nitrogen-containing alicyclic skeleton BONAC CORP (JP) 2013-11-20 — — EP disclosed
EP-2639307-A2 Single-stranded nucleic acid molecule having nitrogen-containing alicyclic skeleton Bonac Corporation (JP) 2013-09-18 — — EP disclosed
EP-2628801-A1 Single-stranded nucleic acid molecule having nitrogen-containing alicyclic skeleton Bonac Corporation (JP) 2013-08-21 — — EP disclosed
EP-2431466-A1 SINGLE-STRAND NUCLEIC ACID MOLECULE FOR CONTROLLING GENE EXPRESSION Bonac Corporation (JP) 2012-03-21 — — EP disclosed
US-20120010271-A1 SINGLE-STRANDED NUCLEIC ACID MOLECULE FOR CONTROLLING GENE EXPRESSION BONAC CORPORATION (JP) 2012-01-12 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120010271-A1 SINGLE-STRANDED NUCLEIC ACID MOLECULE FOR CONTROLLING GENE EXPRESSION SRRT, SSU72, RPRD2 GPBAR1 4338/4885NR1H4 4077/4885CYP3A4 4885/4885
US-20140329886-A1 SINGLE-STRANDED NUCLEIC ACID MOLECULE HAVING AMINO ACID BACKBONE ZFX, YBX1, SRRT GPBAR1 3489/4885NR1H4 1970/4885CYP3A4 4884/4885
US-20140171633-A1 Single-Stranded Nucleic Acid Molecule Having Nitrogen-Containing Alicyclic Skeleton NSUN2, CTDSP1, RNGTT GPBAR1 4322/4885NR1H4 3509/4885CYP3A4 4882/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.